Early diagnosis crucial in ankylosing spondylitis

Practitioner

Volumn 255, Issue 1746, 2011, Pages 21-24

  Malaviya, Anshuman P ^a   Ostor, Andrew J K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALGORITHM; ANKYLOSING SPONDYLITIS; BIOLOGICAL THERAPY; CONFERENCE PAPER; DRUG ANTAGONISM; EARLY DIAGNOSIS; GENETICS; HUMAN;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL THERAPY; EARLY DIAGNOSIS; HLA-B27 ANTIGEN; HUMANS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856276459     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. World Health Organization. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser 2003;919:1-218
2. Reveille JD. Epidemiology of spondyloarthritis in North America. Am J Med Sci 2011;341(4):284-6
3. O'Shea FD, Boyle E, Salonen DC et al. Inflammatory and degenerative sacroiliac joint disease in a primary back pain cohort. Arthritis Care Res (Hoboken) 2010;62:447-54
4. Hamilton L, Gilbert A, Skerrett J et al. Services for people with ankylosing spondylitis in the UK - a survey of rheumatologists and patients. Rheumatology 2011;50(11):1991-8
5. Sheehan NJ. The ramifications of HLA-B27. J R Soc Med 2004;97(1):10-14 (Pubitemid 38121772)
6. Sieper J, Rudwaleit M, Baraliakos X et al. The Assessment of Spondylo Arthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis (Supplement). Ann Rheum Dis 2009;68: ii1-ii44
7. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008;1: CD002822
8. Baraliakos X, Listing J, Fritz C et al. Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years-early clinical response predicts long-term outcome. Rheumatology 2011;50(9):1690-9
9. Braun J, van der Horst-Bruinsma IE, Huang F et al. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. Arthritis Rheum 2011;63(6):1543-51
10. National Institute for Health and Clinical Excellence. TA143. Adalimumab, etanercept and infliximab for ankylosing spondylitis. NICE. London. 2008
11. National Institute for Health and Clinical Excellence. TA233. Golimumab for the treatment of ankylosing spondylitis. NICE. London. 2011
12. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377(9783):2127-37